Basis ( the leading intelligent operating system for autonomous advertising, today announced an agentic AI solution that transforms campaign briefs into strategies and media plans that integrate ...

The US has deployed the EA-37B Compass Call electronic attack platform against Iran in the aircraft’s first known combat ...

A new solution from Basis puts campaign planning into the (figurative) hands of AI agents. But it's just a starting point.

CIH names Rory Golod president of growth, targeting Compass platform adoption for 340,000 agents in 2026 and 2027.

NASHVILLE, Tenn., March 19, 2026 (GLOBE NEWSWIRE) -- The Costigan Group at Compass rolls out a structured pre-acquisition screening framework for short-term rental investors, giving buyers a ...

Investing.com - William Blair reiterated an Outperform rating on Compass Therapeutics (NASDAQ:CMPX) on Thursday as the company reported fourth-quarter earnings and provided a business update. The ...

Compass Therapeutics, Inc. is set to report fourth-quarter and full-year 2025 results on Friday, with investors focused less on the biotech’s expected loss and more on progress toward a potential ...

Treatment-Resistant Depression (TRD) stands as one of the most stubborn and costly challenges in modern healthcare. For the millions of patients who have cycled through multiple antidepressants ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Good morning. I’ve fallen ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced that tomorrow it will report new clinical data from two ...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced that tomorrow it will ...